Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

56.09
+1.793.30%
Pre-market: 56.320.2300+0.41%08:40 EDT
Volume:3.20M
Turnover:175.17M
Market Cap:8.59B
PE:20.26
High:56.27
Open:53.00
Low:52.11
Close:54.30
52wk High:59.30
52wk Low:26.76
Shares:153.09M
Float Shares:141.54M
Volume Ratio:2.34
T/O Rate:2.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):2.77
ROE:100.28%
ROA:7.28%
PB:14.21
PE(LYR):20.25

Loading ...

TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test

Simply Wall St.
·
May 08

TG Therapeutics price target raised to $70 from $60 at H.C. Wainwright

TIPRANKS
·
May 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX) and Insulet (PODD)

TIPRANKS
·
May 07

Stock Track | TG Therapeutics Soars 15.91% Intraday on Raised Revenue Guidance and Strong Q1 Results

Stock Track
·
May 07

TG Therapeutics Up Over 14%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk

Dow Jones
·
May 07

TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

TG Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $70 From $60

THOMSON REUTERS
·
May 06

TG Therapeutics Q1 Adj. EPS $0.18 Misses $0.30 Estimate, Sales $204.918M Beat $196.814M Estimate

Benzinga Earnings
·
May 06

TG Therapeutics Q1 revenue rises, lifts 2026 outlook

Reuters
·
May 06

Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.12, vs. FactSet Est of $0.28

MT Newswires Live
·
May 06

TG Therapeutics Q1 Product Revenue USD 201.308 Million

THOMSON REUTERS
·
May 06

TG Therapeutics Q1 Net Income USD 19.777 Million

THOMSON REUTERS
·
May 06

TG Therapeutics Raises FY 2026 Total Global Revenue Target to Approximately $925 Million

THOMSON REUTERS
·
May 06

TG Therapeutics Q1 EPS USD 0.12

THOMSON REUTERS
·
May 06

Precision Bio Q1 sales beat, helped by milestone revenue

Reuters
·
May 05

TG Therapeutics Inc expected to post earnings of 30 cents a share - Earnings Preview

Reuters
·
May 04

TG Therapeutics announces annual shareholder meeting via webcast

Reuters
·
May 01

TG Therapeutics to host conference call on first-quarter results and 2026 outlook

Reuters
·
Apr 30

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire
·
Apr 22

Goldman Sachs Reaffirms Their Hold Rating on TG Therapeutics (TGTX)

TIPRANKS
·
Apr 16